MedMira (Germany) Top Insiders

47M Stock  EUR 0.03  0  6.76%   
MedMira employs about 5 people. The company is managed by 5 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Examination of MedMira's management performance can provide insight into the company performance.
Stewart McKelvey  Insider
Legal Counsel
Markus Meile  Insider
Chief Officer
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in MedMira. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

MedMira Management Team Effectiveness

The company has return on total asset (ROA) of (0.4547) % which means that it has lost $0.4547 on every $100 spent on assets. This is way below average. MedMira's management efficiency ratios could be used to measure how well MedMira manages its routine affairs as well as how well it operates its assets and liabilities. The current Total Assets is estimated to decrease to about 2.8 M. The current Net Tangible Assets is estimated to decrease to about (11.7 M)
The current Common Stock Shares Outstanding is estimated to decrease to about 741.8 M. The current Net Loss is estimated to decrease to about (2.2 M)MedMira maintains a total of 697.45 Million outstanding shares. MedMira secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 65.54 % of MedMira outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as MedMira in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of MedMira, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

MedMira Workforce Comparison

MedMira is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 1.77 Million. MedMira adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.

MedMira Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. MedMira Price Series Summation is a cross summation of MedMira price series and its benchmark/peer.

MedMira Notable Stakeholders

A MedMira stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as MedMira often face trade-offs trying to please all of them. MedMira's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting MedMira's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Sam RatnamDirector AffairsProfile
Stewart McKelveyLegal CounselProfile
Markus MeileChief OfficerProfile
Hermes ChanCEO, CoFounderProfile
Kevin JonesHead MarketingProfile
String symbol = request.getParameter("s");

About MedMira Management Performance

The success or failure of an entity such as MedMira often depends on how effective the management is. MedMira management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of MedMira management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the MedMira management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Latin America and the Caribbean, Europe, the Asia Pacific, and internationally. The company was founded in 1993 and is headquartered in Halifax, Canada. MEDMIRA INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange.

MedMira Workforce Analysis

Traditionally, organizations such as MedMira use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare MedMira within its industry.

MedMira Manpower Efficiency

Return on MedMira Manpower

Revenue Per Employee48.1K
Revenue Per Executive48.1K
Net Loss Per Employee904.9K
Net Loss Per Executive904.9K

Complementary Tools for MedMira Stock analysis

When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency